Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biocryst Pharmaceuticals Inc (BCRX)  
$6.46 0.11 (1.67%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 189,490,000
Market Cap: 1.22(B)
Last Volume: 3,831,904 Avg Vol: 4,453,128
52 Week Range: $4.13 - $8.81
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 16.2
Insider 6 Months    : 16.2
Insider 3/6 Months : 31.2
Guru Rank Number :  455
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 175,740 175,740 175,740 175,740
Total Buy Value $998,342 $998,342 $998,342 $998,342
Total People Bought 9 9 9 9
Total Buy Transactions 9 9 9 9
Total Shares Sold 0 0 16,866 495,199
Total Sell Value $0 $0 $135,363 $5,999,241
Total People Sold 0 0 2 9
Total Sell Transactions 0 0 2 14
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 475
  Page 19 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stonehouse Jon P President & CEO   •       •      –    2015-01-01 4 D $12.16 $68,728 D/D (5,652) 664,888     -
   Stonehouse Jon P President & CEO   •       •      –    2015-01-01 4 A $0.00 $0 D/D 28,400 670,540     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-12-30 4 S $12.06 $278,634 D/D (23,104) 92,518     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-12-30 4 OE $1.42 $32,808 D/D 23,104 115,622     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-12-29 4 S $12.43 $1,308,817 D/D (105,295) 92,518     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-12-29 4 OE $1.42 $205,742 D/D 48,396 197,813     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-12-29 4 S $12.56 $119,320 D/D (9,500) 162,942     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-12-29 4 OE $3.78 $35,910 D/D 9,500 172,442     -
   Cohen Fred E Director   •       •      –    2014-11-28 4 A $10.81 $8,745 D/D 809 1,457     -
   Cohen Fred E Director   •       •      –    2014-08-29 4 A $13.50 $8,748 D/D 648 648     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-08-27 4 S $13.58 $135,800 D/D (10,000) 162,942     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-08-27 4 OE $5.45 $54,500 D/D 10,000 172,942     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-07-25 4 D $11.76 $100,007 D/D (8,504) 162,252     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-07-25 4 OE $3.78 $100,000 D/D 26,455 170,756     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-07-01 4 AS $13.00 $40,625 D/D (3,125) 144,301     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-07-01 4 OE $4.73 $14,781 D/D 3,125 147,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-06-23 4 AS $12.49 $39,031 D/D (3,125) 144,301     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-06-23 4 OE $4.73 $14,781 D/D 3,125 147,426     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-06-17 4 AS $12.00 $37,500 D/D (3,125) 144,301     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-06-17 4 OE $4.73 $14,781 D/D 3,125 147,426     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-06-03 4 D $9.86 $100,345 D/D (10,177) 148,173     -
   Sheridan William P Senior VP - CMO   •       •      –    2014-06-03 4 OE $4.15 $100,333 D/D 21,228 149,817     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2014-05-22 4 OE $3.78 $66,849 D/D 17,685 144,301     -
   Stonehouse Jon P President & CEO   •       •      –    2014-05-09 4 D $7.70 $232,648 D/D (30,214) 640,445     -
   Stonehouse Jon P President & CEO   •       •      –    2014-05-09 4 OE $3.26 $232,635 D/D 40,417 645,633     -
  475 Records found
  Previous  10  11  12  13  14  15  16  17  18  19    
  Page 19 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us